SEARCH

SEARCH BY CITATION

REFERENCES

  • 1
    Man K, Lo CM, Ng IO, Wong YC, Qin LF, Fan ST, Wong J. Liver transplantation in rats using small-for-size grafts: A study of hemodynamic and morphological changes. Arch Surg 2001; 136: 280285.
  • 2
    Man K, Lo CM, Lee TK, Li XL, Ng IO, Fan ST. Intragraft gene expression profiles by cDNA microarray in small-for-size liver grafts. Liver Transpl 2003; 9: 425432.
  • 3
    Liang TB, Man K, Kin-Wah LT, Hong-Teng TS, Lo CM, Xu X, et al. Distinct intragraft response pattern in relation to graft size in liver transplantation. Transplantation 2003; 75: 673678.
  • 4
    Man K, Lee TK, Liang TB, Lo CM, Fung PC, Tsui SH, et al. FK 409 ameliorates small-for-size liver graft injury by attenuation of portal hypertension and down-regulation of Egr-1 pathway. Ann Surg 2004; 240: 159168.
  • 5
    Zhao Y, Man K, Lo CM, Ng KT, Li XL, Sun CK, et al. Attenuation of small-for-size liver graft injury by FTY720: Significance of cell-survival Akt signaling pathway. Am J Transplant 2004; 4: 13991407.
  • 6
    Man K, Fan ST, Lo CM, Liu CL, Fung PC, Liang TB, et al. Graft injury in relation to graft size in right lobe live donor liver transplantation: A study of hepatic sinusoidal injury in correlation with portal hemodynamics and intragraft gene expression. Ann Surg 2003; 237: 256264.
  • 7
    Zhang JX, Pegoli W Jr, Clemens MG. Endothelin-1 induces direct constriction of hepatic sinusoids. Am J Physiol 1994; 266: G624G632.
  • 8
    Cirera I, Feu F, Luca A, Garcia-Pagan JC, Fernandez M, Escorsell A, et al. Effects of bolus injections and continuous infusions of somatostatin and placebo in patients with cirrhosis: A double-blind hemodynamic investigation. Hepatology 1995; 22: 106111.
  • 9
    Bosch J, Kravetz D, Rodes J. Effects of somatostatin on hepatic and systemic hemodynamics in patients with cirrhosis of the liver: Comparison with vasopressin. Gastroenterology 1981; 80: 518525.
  • 10
    Sonnenberg GE, Keller U, Perruchoud A, Burckhardt D, Gyr K. Effect of somatostatin on splanchnic hemodynamics in patients with cirrhosis of the liver and in normal subjects. Gastroenterology 1981; 80: 526532.
  • 11
    Matrella E, Valatas V, Notas G, Roumpaki H, Xidakis C, Hadzidakis A, et al. Bolus somatostatin but not octreotide reduces hepatic sinusoidal pressure by a NO-independent mechanism in chronic liver disease. Aliment Pharmacol Ther 2001; 15: 857864.
  • 12
    Morris JB, Guerrero NH, Furth EE, Stellato TA. Somatostatin attenuates ischemic intestinal injury. Am J Surg 1993; 165: 676680.
  • 13
    Ferrer JV, Ariceta J, Guerrero D, Balen E, Herrera J, Lera JM. Prevention by somatostatine and N-acetylcisteine of multiorgan failure mediated by oxidative stress after intestinal ischemia. Transplant Proc 1999; 31: 25702571.
  • 14
    Reynaert H, Vaeyens F, Qin H, Hellemans K, Chatterjee N, Winand D, et al. Somatostatin suppresses endothelin-1-induced rat hepatic stellate cell contraction via somatostatin receptor subtype 1. Gastroenterology 2001; 121: 915930.
  • 15
    Lo CM, Liu CL, Fan ST. Portal hyperperfusion injury as the cause of primary nonfunction in a small-for-size liver graft-successful treatment with splenic artery ligation. Liver Transpl 2003; 9: 626628.
  • 16
    Ito T, Kiuchi T, Yamamoto H, Oike F, Ogura Y, Fujimoto Y, et al. Changes in portal venous pressure in the early phase after living donor liver transplantation: pathogenesis and clinical implications. Transplantation 2003; 75: 13131317.
  • 17
    Troisi R, Cammu G, Militerno G, De Baerdemaeker L, Decruyenaere J, Hoste E, et al. Modulation of portal graft inflow: A necessity in adult living-donor liver transplantation? Ann Surg 2003; 237: 429436.
  • 18
    Takada Y, Ueda M, Ishikawa Y, Fujimoto Y, Miyauchi H, Ogura Y, et al. End-to-side portocaval shunting for a small-for-size graft in living donor liver transplantation. Liver Transpl 2004; 10: 807810.
  • 19
    Kravetz D, Bosch J, Arderiu MT, Pizcueta MP, Casamitjana R, Rivera F, et al. Effects of somatostatin on splanchnic hemodynamics and plasma glucagon in portal hypertensive rats. Am J Physiol 1988; 254: G322G328.
  • 20
    Schwartz SM. A protective player in the vascular response to injury. Nat Med 2001; 7: 656657.
  • 21
    Coito AJ, Buelow R, Shen XD, Amersi F, Moore C, Volk HD, et al. Heme oxygenase-1 gene transfer inhibits inducible nitric oxide synthase expression and protects genetically fat Zucker rat livers from ischemia-reperfusion injury. Transplantation 2002; 74: 96102.
  • 22
    Sass G, Koerber K, Bang R, Guehring H, Tiegs G. Inducible nitric oxide synthase is critical for immune-mediated liver injury in mice. J Clin Invest 2001; 107: 439447.
  • 23
    Arvelo MB, Cooper JT, Longo C, Daniel S, Grey ST, Mahiou J, et al. A20 protects mice from D-galactosamine/lipopolysaccharide acute toxic lethal hepatitis. Hepatology 2002; 35: 535543.
  • 24
    Gao W, Bentley RC, Madden JF, Clavien PA. Apoptosis of sinusoidal endothelial cells is a critical mechanism of preservation injury in rat liver transplantation. Hepatology 1998; 27: 16521660.
  • 25
    Mearadji A, Breeman W, Hofland L, van Koetsveld P, Marquet R, Jeekel J, et al. Somatostatin receptor gene therapy combined with targeted therapy with radiolabeled octreotide: A new treatment for liver metastases. Ann Surg 2002; 236: 722728; discussion 728–729.
  • 26
    Lasfer M, Vadrot N, Schally AV, Nagy A, Halmos G, Pessayre D, et al. Potent induction of apoptosis in human hepatoma cell lines by targeted cytotoxic somatostatin analogue AN-238. J Hepatol 2005; 42: 230237.